Screener
Ligand Pharmaceuticals LGND Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's book value per share?
- Ligand Pharmaceuticals (LGND) reported book value per share of $44.31 in Q2 2026.
- How has Ligand Pharmaceuticals's book value per share changed year-over-year?
- Ligand Pharmaceuticals's book value per share increased by 6.7% year-over-year, from $41.52 to $44.31.
- What is the long-term trend for Ligand Pharmaceuticals's book value per share?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's book value per share has grown at a 3.3% compound annual growth rate (CAGR), from $42.53 to $50.12.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Ligand Pharmaceuticals's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude